Pfeifer1982: haha... we will be here all year splitting hairs about the results from your little cohort group. I am not concerned about our old dosage requirements. I believe that potency has improved with current production methods and that efficacy is more than sufficient to assure MSB of a highly successful treatment for aGVHD ... (judging by the Colarado Hospital stats). We are now essentially talking about operating margins between two differing production methodologies. My point to you is that first mover advantage will always be key. If we need to use iPS in the future we have our own patent thank you very much .Your posts are improving in their accuracy and becoming a little less biased. I also appreciate your good humour in their delivery I wish you well. Now we understand each other, I will now move on to other tasks before we bore everyone to death.
- Forums
- ASX - By Stock
- MSB trading
Pfeifer1982: haha... we will be here all year splitting hairs...
-
-
- There are more pages in this discussion • 79 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.40 |
Change
-0.070(4.78%) |
Mkt cap ! $1.581B |
Open | High | Low | Value | Volume |
$1.45 | $1.46 | $1.37 | $6.047M | 4.308M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
15 | 220242 | $1.39 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.40 | 2520 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 29989 | 1.395 |
11 | 146150 | 1.390 |
10 | 59375 | 1.385 |
13 | 204550 | 1.380 |
6 | 41481 | 1.375 |
Price($) | Vol. | No. |
---|---|---|
1.400 | 124379 | 9 |
1.405 | 16130 | 7 |
1.410 | 63340 | 9 |
1.415 | 200507 | 13 |
1.420 | 45778 | 5 |
Last trade - 13.37pm 09/10/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
AHK
ARK MINES LIMITED
Ben Emery, Executive Director
Ben Emery
Executive Director
SPONSORED BY The Market Online